Monday, September 14, 2026

[Exclusive] HLB’s Liver Cancer Drug Clears Camrelizumab CMC Review, but Hengrui Manufacturing Facility Becomes New Hurdle

HLB's liver cancer drug approval faces delays due to FDA findings at Hengrui's facility, despite resolution of previous issues.

AWS lights up Korean dev scene with GenAI Amazon Q

AWS enhances its generative AI service, Amazon Q Developer, to support Korean, aiding local developers in various tasks.

Intel’s Stock Soars 7% as U.S. Government Backs Domestic Chip Production

Intel's stock surged over 7% due to a partnership with TSMC and U.S. government support for domestic semiconductor production.

Kyo Hyun Kang

Author's Latest

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.